Screening Antibiotics for the Elimination of Bacteria ... - AU Journal
Screening Antibiotics for the Elimination of Bacteria ... - AU Journal
Screening Antibiotics for the Elimination of Bacteria ... - AU Journal
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>AU</strong> J.T. 16(1): 7-18 (Jul. 2012)<br />
Table 1. Inhibitory zones (mm) around discs containing different concentrations <strong>of</strong> various<br />
antibiotics placed on <strong>the</strong> surface <strong>of</strong> Mueller-Hinton agar (MHA) medium inoculated with <strong>the</strong><br />
standardized yam tissue culture bacterial contaminants.<br />
<strong>Bacteria</strong><br />
Burkholderia<br />
spp.<br />
Luteibacter<br />
rhizovinus<br />
Bacillus<br />
cereus<br />
<strong>Antibiotics</strong><br />
Concentration (µg/ml)<br />
3.9 7.8 15.6 31.3 63 125 250 500 1,000<br />
Rifampicin 10.2 11 12 12.7 14.2 16.3 17.8 18.7 20<br />
Sterptomycin 0 5.2 7.2 10.2 14.7 15.5 18.8 19.3 21.2<br />
Vancomycin 0 0 1.5 1.3 4.3 11.5 13 15.2 17.7<br />
Gentamycin 0 0 3 11.7 14.3 18.7 20 21.3 25.2<br />
Tetracycline 0 0 0 0 4 8.7 9 11 13<br />
Ampicillin 0 0 0 0 2 0 2 1.3 8.5<br />
Penicillin G 0 0 0 0 0 0 0 7.8 9.7<br />
Ce<strong>for</strong>taxime 0 0 0 0 0 0 0 4.8 10.8<br />
Bacitracin 0 0 0 0 0 0 0 0 4.8<br />
Trimetoprim 0 0 0 0 0 0 0 0 0<br />
Carbenicillin 0 0 0 0 0 0 0 0 0<br />
Control 0 0 0 0 0 0 0 0 0<br />
LSD 0.3 2 2.8 2.2 2.5 1.2 1.2 2.3 2.1<br />
Rifampicin 9.7 9.8 11 12 13 14.3 15.3 17 17.5<br />
Sterptomycin 0 6.5 12 11.5 16.7 17.7 19 20.2 21.7<br />
Vancomycin 0 0 2.7 4.2 8.2 13.2 13.2 16 16.7<br />
Gentamycin 0 0 3 11 14.7 17.5 18.5 22 22.8<br />
Tetracycline 0 0 0 1.7 10.2 12.7 12.7 15 17.8<br />
Ampicillin 0 0 0 0 0 0 0 5 11<br />
Penicillin G 0 0 0 0 0 0 0 2.8 6.3<br />
Ce<strong>for</strong>taxime 0 0 0 0 0 0 0 1.5 12<br />
Bacitracin 0 0 0 0 0 0 0 1.5 8<br />
Trimetoprim 0 0 0 0 0 0 0 0 0<br />
Carbenicillin 0 0 0 0 0 0 0 0 0<br />
Control 0 0 0 0 0 0 0 0 0<br />
LSD 0.4 1.8 2.3 2.2 1.7 1.2 1.2 3.1 2.3<br />
Rifampicin 10.3 11 13 13.8 15.5 17.2 16.3 21.5 22<br />
Sterptomycin 0 0 4 8.7 13 13.8 15.8 17.2 20.2<br />
Vancomycin 0 0 0 1.5 4 11.7 13 16 18.3<br />
Gentamycin 0 0 4 11.8 16.7 19.3 21.5 23.8 25<br />
Tetracycline 0 0 0 0 3.8 4.2 9.3 10.8 12.7<br />
Ampicillin 0 0 0 0 0 0 4.2 2.8 9.5<br />
Penicillin G 0 0 0 0 0 0 0 1.5 9<br />
Ce<strong>for</strong>taxime 0 0 0 0 0 0 0 0 10.5<br />
Bacitracin 0 0 0 0 0 0 0 0 5<br />
Trimetoprim 0 0 0 0 0 0 0 0 0<br />
Carbenicillin 0 0 0 0 0 0 0 0 0<br />
Control 0 0 0 0 0 0 0 0 0<br />
LSD 0.4 0.7 3 2.3 2.5 2.1 1.8 2.8 3.7<br />
3.3 Combination <strong>of</strong> Two <strong>Antibiotics</strong><br />
From <strong>the</strong> initial 11 antibiotics screened by <strong>the</strong><br />
disc diffusion assays, <strong>the</strong> 5 antibiotics that<br />
showed effectiveness were subjected to fur<strong>the</strong>r<br />
analysis and 10 combination treatments were<br />
obtained from <strong>the</strong> combination <strong>of</strong> antibiotics in<br />
two’s. Representative results <strong>of</strong> <strong>the</strong> disc<br />
diffusion assays, with varying concentrations<br />
<strong>of</strong> <strong>the</strong> combination <strong>of</strong> two antibiotics<br />
treatments are shown in Tables 2 and 4.<br />
Research Paper 11